Apr 24, 2025 | Defective Drugs, Defective Medical Device, Defective Product, Depo-Provera, Product Liability
For decades, Depo-Provera has been marketed as a convenient and long-lasting form of birth control. The injectable contraceptive, also known as depot medroxyprogesterone acetate (DMPA), has been widely prescribed to millions of women in the United States and around...
Feb 26, 2025 | Defective Drugs, Depo-Provera, Multidistrict Litigation, Product Liability
For decades, Depo-Provera has been a widely used injectable contraceptive. It often receives praise for its convenience and long-term effectiveness. However, recent lawsuits are emerging linking Depo-Provera to serious health risks, including the development of...
Dec 4, 2024 | Defective Drugs, Defective Product, Depo-Provera, Product Liability
Depo-Provera, a widely used birth control injection, has been hailed as a convenient option for women seeking long-term contraception. However, the medication has come under scrutiny due to reports of severe side effects and complications, including an increased risk...
Nov 19, 2024 | Defective Drugs, Defective Product, Depo-Provera, Product Liability
Depo-Provera, an injectable contraceptive containing the synthetic hormone medroxyprogesterone acetate (MPA), has been widely used for decades as an effective birth control method. While it is valued for its convenience and long-term efficacy, concerns have emerged...
Oct 24, 2024 | Defective Drugs, Depo-Provera, Product Liability
Depo-Provera, a popular birth control injection used by millions of women worldwide, has long been lauded for its convenience and efficacy. However, new evidence has surfaced that may change how women view this contraceptive option. Recent studies and emerging reports...
